3rd Quarter - Report

FORBES-TATE for EMERGENT BIOSOLUTIONS

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act; H.R.7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to biological and chemical defense and access to naloxone; Issues related to H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0; H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022; S. 3799 - PREVENT Pandemics Act.

Contacted: Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS)

Bills named: S. 3799 (117th), H.R. 6119 (117th), H.R. 7900 (117th), H.R. 3263 (117th), H.R. 7666 (117th), H.R. 7681 (117th)

Budget/Appropriations BUD

Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987/H.R. 4341 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Appropriations funding for FY23 related to medical countermeasures and opioid overdose.

Contacted: SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Centers For Disease Control & Prevention (CDC); Office of Natl Drug Control Policy (NDCP); Office of Management & Budget (OMB)

Bills named: S. 987 (117th), H.R. 2366 (117th), S. 1457 (117th), H.R. 4341 (117th), H.R. 6119 (117th), H.R. 2379 (117th), H.R. 5224 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.